For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.
The global robo advisory market is segmented into business model, service provider, service type, end user, and region. In terms of business model, the market is fragmented into pure robo-advisors and ...
Technological Advancements: Innovations such as artificial intelligence, blockchain, and big data analytics are revolutionizing the BFSI sector. These technologies empower institutions to automate ...